Ascelia Pharma: Time for take-off

Research Update

2024-05-20

08:19

Ascelia’s Q1 result was minor compared to the recent SPARKLE success. Ascelia is preparing for submission by mid-2025, and Ascelia’s cost base was contained. Our Base Case is SEK 17 (Bull SEK 45 and Bear SEK 6).

JU

Johan Unnerus

Disclosures and disclaimers

Premium Plan required to unlock

Unlock companies to access

more high quality research.